Pro Share Advisors LLC Alaunos Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.12 - $0.5 $19 - $80	161 Added 1.03%	15,731 $2,000
Q2 2023 Aug 10, 2023	SELL	$0.43 - $0.65 $471 - $713	-1,097 Reduced 6.58%	15,570 $7,000
Q1 2023 May 11, 2023	SELL	$0.46 - $0.81 $1,479 - $2,604	-3,216 Reduced 16.17%	16,667 $10,000
Q4 2022 Feb 02, 2023	BUY	$0.5 - $261.0 $848 - $442,917	1,697 Added 9.33%	19,883 $12,000
Q3 2022 Nov 04, 2022	BUY	$1.04 - $322.5 $1,422 - $441,180	1,368 Added 8.13%	18,186 $31,000
Q2 2022 Aug 01, 2022	SELL	$0.41 - $1.24 $18,388 - $55,614	-44,850 Reduced 72.73%	16,818 $21,000
Q1 2022 May 10, 2022	SELL	$0.62 - $1.17 $9,032 - $17,044	-14,568 Reduced 19.11%	61,668 $41,000
Q4 2021 Feb 08, 2022	BUY	$1.09 - $1.89 $3,620 - $6,278	3,322 Added 4.56%	76,236 $83,000
Q3 2021 Nov 12, 2021	SELL	$1.44 - $2.73 $29,075 - $55,121	-20,191 Reduced 21.69%	72,914 $133,000
Q2 2021 Aug 13, 2021	BUY	$2.63 - $3.67 $17,060 - $23,807	6,487 Added 7.49%	93,105 $246,000
Q1 2021 May 14, 2021	BUY	$2.82 - $5.6 $17,830 - $35,408	6,323 Added 7.87%	86,618 $312,000
Q4 2020 Feb 09, 2021	BUY	$2.09 - $3.09 $113,200 - $167,363	54,163 Added 207.27%	80,295 $202,000
Q3 2020 Nov 13, 2020	SELL	$2.39 - $3.43 $6,789 - $9,744	-2,841 Reduced 9.81%	26,132 $66,000
Q2 2020 Aug 03, 2020	BUY	$2.2 - $3.71 $39,974 - $67,410	18,170 Added 168.19%	28,973 $95,000
Q1 2020 May 15, 2020	SELL	$1.9 - $4.98 $20,824 - $54,580	-10,960 Reduced 50.36%	10,803 $26,000
Q4 2019 Feb 12, 2020	BUY	$3.95 - $5.35 $13,738 - $18,607	3,478 Added 19.02%	21,763 $103,000
Q3 2019 Nov 12, 2019	BUY	$4.13 - $6.94 $17,940 - $30,147	4,344 Added 31.16%	18,285 $78,000
Q2 2019 Aug 13, 2019	SELL	$3.98 - $6.2 $1,456 - $2,269	-366 Reduced 2.56%	13,941 $81,000
Q1 2019 May 15, 2019	BUY	$2.0 - $4.4 $892 - $1,962	446 Added 3.22%	14,307 $55,000
Q4 2018 Feb 14, 2019	SELL	$1.61 - $3.62 $3,598 - $8,090	-2,235 Reduced 13.89%	13,861 $26,000
Q3 2018 Nov 14, 2018	SELL	$2.26 - $3.27 $2,791 - $4,038	-1,235 Reduced 7.13%	16,096 $52,000
Q2 2018 Aug 13, 2018	BUY	$3.02 - $4.94 $1,621 - $2,652	537 Added 3.2%	17,331 $52,000
Q1 2018 May 14, 2018	SELL	$3.46 - $5.14 $9,380 - $13,934	-2,711 Reduced 13.9%	16,794 $66,000
Q4 2017 Feb 14, 2018	BUY	$4.0 - $6.54 $78,020 - $127,562	19,505 New	19,505 $81,000
Q3 2017 Nov 13, 2017	SELL	$4.99 - $6.57 $57,923 - $76,264	-11,608 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	11,608	11,608 $72,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $493M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account